

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.92082693 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.92082693 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.40573602 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.18091257 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.77975519 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.77975519 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.59208003 |
| 8 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.32004536 |
| 9 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.13216319 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.87594420 |
| 11 | response to type I interferon (GO:0034340) | 3.83371298 |
| 12 | cellular response to type I interferon (GO:0071357) | 3.83032740 |
| 13 | type I interferon signaling pathway (GO:0060337) | 3.83032740 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.77196502 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.77196502 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.77196502 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.77196502 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.77196502 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.77196502 |
| 20 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.76115399 |
| 21 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.66391689 |
| 22 | positive thymic T cell selection (GO:0045059) | 3.64891409 |
| 23 | positive regulation of interferon-alpha production (GO:0032727) | 3.62403833 |
| 24 | interferon-gamma production (GO:0032609) | 3.50690861 |
| 25 | regulation of interferon-alpha production (GO:0032647) | 3.47010995 |
| 26 | T cell migration (GO:0072678) | 3.43774703 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 3.42003755 |
| 28 | positive regulation of humoral immune response (GO:0002922) | 3.40419197 |
| 29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39526158 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 3.38742384 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 3.34773949 |
| 32 | thymic T cell selection (GO:0045061) | 3.31391876 |
| 33 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.30522869 |
| 34 | T cell selection (GO:0045058) | 3.29821452 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.26271738 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 3.22330899 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 3.20771329 |
| 38 | B cell mediated immunity (GO:0019724) | 3.19930622 |
| 39 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.17000719 |
| 40 | tryptophan catabolic process (GO:0006569) | 3.16897665 |
| 41 | indole-containing compound catabolic process (GO:0042436) | 3.16897665 |
| 42 | indolalkylamine catabolic process (GO:0046218) | 3.16897665 |
| 43 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.15475316 |
| 44 | immunoglobulin mediated immune response (GO:0016064) | 3.12793465 |
| 45 | detection of external biotic stimulus (GO:0098581) | 3.09969067 |
| 46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.09862272 |
| 47 | positive T cell selection (GO:0043368) | 3.06831565 |
| 48 | regulation of T cell tolerance induction (GO:0002664) | 3.06426762 |
| 49 | response to interferon-alpha (GO:0035455) | 3.06083114 |
| 50 | complement activation, alternative pathway (GO:0006957) | 3.03210783 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.02100536 |
| 52 | negative T cell selection (GO:0043383) | 3.01876217 |
| 53 | tolerance induction (GO:0002507) | 3.00428749 |
| 54 | response to host immune response (GO:0052572) | 2.98992605 |
| 55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.98992605 |
| 56 | response to interferon-beta (GO:0035456) | 2.97401061 |
| 57 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.97196418 |
| 58 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.96190136 |
| 59 | tryptophan metabolic process (GO:0006568) | 2.95674033 |
| 60 | leukocyte aggregation (GO:0070486) | 2.94884315 |
| 61 | cellular response to interferon-beta (GO:0035458) | 2.94369016 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93457135 |
| 63 | positive regulation of granulocyte differentiation (GO:0030854) | 2.91120101 |
| 64 | aromatic amino acid family catabolic process (GO:0009074) | 2.90613108 |
| 65 | regulation of antigen processing and presentation (GO:0002577) | 2.90037908 |
| 66 | positive regulation of interferon-beta production (GO:0032728) | 2.88578361 |
| 67 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.87154057 |
| 68 | regulation of B cell differentiation (GO:0045577) | 2.86879620 |
| 69 | cellular response to interleukin-15 (GO:0071350) | 2.86420899 |
| 70 | defense response to protozoan (GO:0042832) | 2.86169460 |
| 71 | regulation of RIG-I signaling pathway (GO:0039535) | 2.85807518 |
| 72 | mature B cell differentiation (GO:0002335) | 2.85606044 |
| 73 | negative thymic T cell selection (GO:0045060) | 2.85174373 |
| 74 | regulation of tolerance induction (GO:0002643) | 2.84553606 |
| 75 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83602201 |
| 76 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83148500 |
| 77 | negative regulation of innate immune response (GO:0045824) | 2.79693143 |
| 78 | respiratory burst (GO:0045730) | 2.79440399 |
| 79 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.77088866 |
| 80 | protein carboxylation (GO:0018214) | 2.76486887 |
| 81 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.76486887 |
| 82 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.76062980 |
| 83 | myeloid cell activation involved in immune response (GO:0002275) | 2.75836190 |
| 84 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.74956247 |
| 85 | germinal center formation (GO:0002467) | 2.73589025 |
| 86 | response to interleukin-15 (GO:0070672) | 2.72992305 |
| 87 | myeloid dendritic cell activation (GO:0001773) | 2.72925566 |
| 88 | B cell receptor signaling pathway (GO:0050853) | 2.72896062 |
| 89 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.72304537 |
| 90 | T-helper cell differentiation (GO:0042093) | 2.72304537 |
| 91 | response to peptidoglycan (GO:0032494) | 2.71196041 |
| 92 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.70943462 |
| 93 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.70126103 |
| 94 | response to host (GO:0075136) | 2.69362767 |
| 95 | response to host defenses (GO:0052200) | 2.69362767 |
| 96 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.69362767 |
| 97 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.68659485 |
| 98 | cellular response to interferon-gamma (GO:0071346) | 2.68399988 |
| 99 | urea metabolic process (GO:0019627) | 2.68228860 |
| 100 | urea cycle (GO:0000050) | 2.68228860 |
| 101 | detection of biotic stimulus (GO:0009595) | 2.68216544 |
| 102 | NAD biosynthetic process (GO:0009435) | 2.68066747 |
| 103 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.67355433 |
| 104 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.67334646 |
| 105 | mature B cell differentiation involved in immune response (GO:0002313) | 2.67152209 |
| 106 | regulation of protein activation cascade (GO:2000257) | 2.66321317 |
| 107 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.65900741 |
| 108 | negative regulation of viral genome replication (GO:0045071) | 2.64499725 |
| 109 | NIK/NF-kappaB signaling (GO:0038061) | 2.64176168 |
| 110 | neutrophil activation involved in immune response (GO:0002283) | 2.63382125 |
| 111 | kynurenine metabolic process (GO:0070189) | 2.62696115 |
| 112 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.62398566 |
| 113 | positive regulation of B cell mediated immunity (GO:0002714) | 2.62398566 |
| 114 | cellular extravasation (GO:0045123) | 2.62040385 |
| 115 | response to protozoan (GO:0001562) | 2.61946155 |
| 116 | interferon-gamma secretion (GO:0072643) | 2.61664235 |
| 117 | detection of other organism (GO:0098543) | 2.60645167 |
| 118 | detection of bacterium (GO:0016045) | 2.59816380 |
| 119 | myeloid dendritic cell differentiation (GO:0043011) | 2.59813864 |
| 120 | mast cell activation (GO:0045576) | 2.59050308 |
| 121 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.58316434 |
| 122 | L-phenylalanine catabolic process (GO:0006559) | 2.58316434 |
| 123 | regulation of humoral immune response (GO:0002920) | 2.58242107 |
| 124 | response to muramyl dipeptide (GO:0032495) | 2.58142549 |
| 125 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.57074602 |
| 126 | lymph node development (GO:0048535) | 2.56888528 |
| 127 | positive regulation of type 2 immune response (GO:0002830) | 2.56470484 |
| 128 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.56202095 |
| 129 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.56202095 |
| 130 | Peyers patch development (GO:0048541) | 2.55882086 |
| 131 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.55882086 |
| 132 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.54653310 |
| 133 | cellular response to exogenous dsRNA (GO:0071360) | 2.54483161 |
| 134 | macrophage activation involved in immune response (GO:0002281) | 2.53443169 |
| 135 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.53082784 |
| 136 | bile acid biosynthetic process (GO:0006699) | 2.52892285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.89150170 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.78118747 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.63062577 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.39366846 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.33518024 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.14452257 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.07721328 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.70001074 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.08280858 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.01314021 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.97297216 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.92003555 |
| 13 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.86586632 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.84505691 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.83378061 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73968675 |
| 17 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.70686267 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.70362764 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63353690 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.48638600 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.33226722 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29129203 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26360242 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.25409287 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.18532744 |
| 26 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.17587061 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.10757773 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08554065 |
| 29 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.99317514 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.97355331 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93576869 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92496152 |
| 33 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.87847211 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.86947478 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.84820726 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.83041396 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.82845003 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.82316242 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80400529 |
| 40 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.79973394 |
| 41 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71032679 |
| 42 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.70546358 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.70248134 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67061804 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64362727 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.63349718 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61750531 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59423712 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58590325 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.58285357 |
| 51 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54136629 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54010573 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.53482910 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52592778 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.49335148 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48238440 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46133457 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43660825 |
| 59 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40313650 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39640743 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38875016 |
| 62 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.38296823 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37926258 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35882448 |
| 65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.34749329 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32471777 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28863874 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26452814 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25220493 |
| 70 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.24210394 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24192316 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23965506 |
| 73 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21954599 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20930125 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19953706 |
| 76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.19380641 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18187101 |
| 78 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16021189 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15265015 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12331662 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12235062 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11322965 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10750125 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 1.09967531 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09544327 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09242552 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07440800 |
| 88 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06896592 |
| 89 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06476651 |
| 90 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04763745 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03374555 |
| 92 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01934482 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 1.01319503 |
| 94 | * MYC_22102868_ChIP-Seq_BL_Human | 1.00022647 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98897919 |
| 96 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98056399 |
| 97 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96940357 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96289848 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95646556 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94799106 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93557751 |
| 102 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93131613 |
| 103 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92946167 |
| 104 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92840194 |
| 105 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92002577 |
| 106 | P300_27268052_Chip-Seq_Bcells_Human | 0.90317558 |
| 107 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89215636 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89015242 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88233761 |
| 110 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85113035 |
| 111 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83966803 |
| 112 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81281235 |
| 113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80368458 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77684199 |
| 115 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.73069172 |
| 116 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.72298791 |
| 117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.71347863 |
| 118 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.69915650 |
| 119 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.67783309 |
| 120 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67649599 |
| 121 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.66200214 |
| 122 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.66191760 |
| 123 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.65815143 |
| 124 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.65691889 |
| 125 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.64860485 |
| 126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60996208 |
| 127 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.60936775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.95101243 |
| 2 | MP0009785_altered_susceptibility_to | 3.31603619 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.15395273 |
| 4 | MP0005671_abnormal_response_to | 3.10662901 |
| 5 | MP0005360_urolithiasis | 3.01555934 |
| 6 | MP0003436_decreased_susceptibility_to | 2.91201560 |
| 7 | MP0000685_abnormal_immune_system | 2.88852480 |
| 8 | MP0005387_immune_system_phenotype | 2.67025059 |
| 9 | MP0001790_abnormal_immune_system | 2.67025059 |
| 10 | MP0001800_abnormal_humoral_immune | 2.65790432 |
| 11 | MP0005025_abnormal_response_to | 2.61746802 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.47015844 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.46609240 |
| 14 | MP0005365_abnormal_bile_salt | 2.42932210 |
| 15 | MP0002419_abnormal_innate_immunity | 2.36876658 |
| 16 | MP0002723_abnormal_immune_serum | 2.35793624 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.35071894 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.32402431 |
| 19 | MP0003724_increased_susceptibility_to | 2.26331619 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.25216958 |
| 21 | MP0006082_CNS_inflammation | 2.23063966 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.18250380 |
| 23 | MP0001819_abnormal_immune_cell | 2.10318146 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.10150255 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.93305371 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.88957951 |
| 27 | MP0009840_abnormal_foam_cell | 1.87366436 |
| 28 | MP0001853_heart_inflammation | 1.79445392 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.78696744 |
| 30 | MP0002398_abnormal_bone_marrow | 1.78365606 |
| 31 | MP0002006_tumorigenesis | 1.77025986 |
| 32 | MP0008469_abnormal_protein_level | 1.77010237 |
| 33 | MP0004381_abnormal_hair_follicle | 1.74806158 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.74791780 |
| 35 | MP0000716_abnormal_immune_system | 1.74115897 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.72012699 |
| 37 | MP0009764_decreased_sensitivity_to | 1.70930837 |
| 38 | MP0004510_myositis | 1.63885172 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.62185889 |
| 40 | MP0004947_skin_inflammation | 1.61854278 |
| 41 | MP0003252_abnormal_bile_duct | 1.59509184 |
| 42 | MP0002405_respiratory_system_inflammati | 1.57643065 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.51964895 |
| 44 | MP0002722_abnormal_immune_system | 1.48705809 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.47516673 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.44570605 |
| 47 | MP0001873_stomach_inflammation | 1.43740363 |
| 48 | MP0002429_abnormal_blood_cell | 1.42298906 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.41811355 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.40860979 |
| 51 | MP0009278_abnormal_bone_marrow | 1.40198076 |
| 52 | MP0009763_increased_sensitivity_to | 1.39992371 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.39212047 |
| 54 | MP0000609_abnormal_liver_physiology | 1.38417204 |
| 55 | MP0005310_abnormal_salivary_gland | 1.38376221 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.34218677 |
| 57 | MP0002009_preneoplasia | 1.31191759 |
| 58 | MP0003866_abnormal_defecation | 1.31026765 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.30801977 |
| 60 | MP0003303_peritoneal_inflammation | 1.27957752 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.27344178 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.26649494 |
| 63 | MP0005083_abnormal_biliary_tract | 1.15600835 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.15523517 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.15523517 |
| 66 | MP0001666_abnormal_nutrient_absorption | 1.14340718 |
| 67 | MP0001764_abnormal_homeostasis | 1.11624412 |
| 68 | MP0003868_abnormal_feces_composition | 1.07698552 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.06922281 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.05791998 |
| 71 | MP0001663_abnormal_digestive_system | 1.05460134 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 1.04403848 |
| 73 | MP0000490_abnormal_crypts_of | 1.03345664 |
| 74 | MP0002132_abnormal_respiratory_system | 1.02469476 |
| 75 | MP0003075_altered_response_to | 1.02067998 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 1.01099533 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 1.00929749 |
| 78 | MP0005451_abnormal_body_composition | 1.00496062 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 0.99023812 |
| 80 | MP0003045_fibrosis | 0.98692312 |
| 81 | MP0004019_abnormal_vitamin_homeostasis | 0.97191730 |
| 82 | MP0003172_abnormal_lysosome_physiology | 0.95586697 |
| 83 | MP0009697_abnormal_copulation | 0.94420678 |
| 84 | MP0005076_abnormal_cell_differentiation | 0.94001482 |
| 85 | MP0003195_calcinosis | 0.93594297 |
| 86 | MP0003186_abnormal_redox_activity | 0.92962600 |
| 87 | MP0002933_joint_inflammation | 0.91803146 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 0.91658533 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.89569513 |
| 90 | MP0001851_eye_inflammation | 0.89413533 |
| 91 | MP0000858_altered_metastatic_potential | 0.89150095 |
| 92 | MP0005332_abnormal_amino_acid | 0.87969633 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.87704614 |
| 94 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87165577 |
| 95 | MP0000598_abnormal_liver_morphology | 0.86428981 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 0.85858621 |
| 97 | MP0003448_altered_tumor_morphology | 0.85380431 |
| 98 | MP0008260_abnormal_autophagy | 0.83742438 |
| 99 | MP0003453_abnormal_keratinocyte_physiol | 0.79900857 |
| 100 | MP0004883_abnormal_blood_vessel | 0.78703838 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.75744400 |
| 102 | MP0005647_abnormal_sex_gland | 0.75334392 |
| 103 | MP0003183_abnormal_peptide_metabolism | 0.74168662 |
| 104 | MP0002928_abnormal_bile_duct | 0.73130438 |
| 105 | MP0005166_decreased_susceptibility_to | 0.72922184 |
| 106 | MP0005164_abnormal_response_to | 0.71633992 |
| 107 | MP0009643_abnormal_urine_homeostasis | 0.71433752 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.69542713 |
| 109 | MP0010234_abnormal_vibrissa_follicle | 0.69093926 |
| 110 | MP0009642_abnormal_blood_homeostasis | 0.69062178 |
| 111 | MP0000604_amyloidosis | 0.67245507 |
| 112 | MP0002095_abnormal_skin_pigmentation | 0.66515000 |
| 113 | MP0004858_abnormal_nervous_system | 0.66164710 |
| 114 | MP0002019_abnormal_tumor_incidence | 0.66055750 |
| 115 | MP0000477_abnormal_intestine_morphology | 0.65025002 |
| 116 | MP0000371_diluted_coat_color | 0.64960314 |
| 117 | MP0005381_digestive/alimentary_phenotyp | 0.62085411 |
| 118 | MP0000249_abnormal_blood_vessel | 0.61922858 |
| 119 | MP0005390_skeleton_phenotype | 0.61688541 |
| 120 | MP0010307_abnormal_tumor_latency | 0.58751261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 4.29319168 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.27318830 |
| 3 | Joint hemorrhage (HP:0005261) | 4.22046607 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.04892782 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.02657758 |
| 6 | Myositis (HP:0100614) | 4.02382075 |
| 7 | Eczematoid dermatitis (HP:0000976) | 3.96599436 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 3.93356322 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.92279102 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.69743505 |
| 11 | Optic neuritis (HP:0100653) | 3.69743505 |
| 12 | Orchitis (HP:0100796) | 3.65949698 |
| 13 | Gingival bleeding (HP:0000225) | 3.48067780 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.42333419 |
| 15 | Increased IgE level (HP:0003212) | 3.36736790 |
| 16 | Recurrent viral infections (HP:0004429) | 3.23522159 |
| 17 | Recurrent skin infections (HP:0001581) | 3.23428096 |
| 18 | Complement deficiency (HP:0004431) | 3.19801146 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 3.16126502 |
| 20 | Vasculitis (HP:0002633) | 3.13911047 |
| 21 | Nasal polyposis (HP:0100582) | 3.13204676 |
| 22 | Recurrent bronchitis (HP:0002837) | 3.11987063 |
| 23 | Meningitis (HP:0001287) | 3.10331438 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.08456230 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.08456230 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.07117538 |
| 27 | Intrahepatic cholestasis (HP:0001406) | 3.06994006 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.04576420 |
| 29 | Stomatitis (HP:0010280) | 2.96287808 |
| 30 | Epistaxis (HP:0000421) | 2.93195782 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.92022575 |
| 32 | Gastrointestinal stroma tumor (HP:0100723) | 2.87265535 |
| 33 | Abnormality of macrophages (HP:0004311) | 2.81403390 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.80889722 |
| 35 | Prolonged bleeding time (HP:0003010) | 2.80087108 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 2.79600350 |
| 37 | IgM deficiency (HP:0002850) | 2.79584894 |
| 38 | Deep venous thrombosis (HP:0002625) | 2.78324812 |
| 39 | Encephalitis (HP:0002383) | 2.73834724 |
| 40 | Abnormality of T cell number (HP:0011839) | 2.73260035 |
| 41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.71849886 |
| 42 | Agammaglobulinemia (HP:0004432) | 2.70910737 |
| 43 | Keratoconjunctivitis sicca (HP:0001097) | 2.69960713 |
| 44 | Inflammation of the large intestine (HP:0002037) | 2.68479083 |
| 45 | T lymphocytopenia (HP:0005403) | 2.68190887 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.67634753 |
| 47 | Abnormality of the fingertips (HP:0001211) | 2.63234687 |
| 48 | Menorrhagia (HP:0000132) | 2.62929529 |
| 49 | Arterial thrombosis (HP:0004420) | 2.62716200 |
| 50 | Abnormality of the nasal mucosa (HP:0000433) | 2.62133515 |
| 51 | Abnormality of the common coagulation pathway (HP:0010990) | 2.61241928 |
| 52 | Abnormality of T cells (HP:0002843) | 2.59501521 |
| 53 | Pustule (HP:0200039) | 2.57897001 |
| 54 | Malnutrition (HP:0004395) | 2.56722182 |
| 55 | Pulmonary embolism (HP:0002204) | 2.56339533 |
| 56 | Granulocytopenia (HP:0001913) | 2.54977740 |
| 57 | Panhypogammaglobulinemia (HP:0003139) | 2.54479357 |
| 58 | Xanthomatosis (HP:0000991) | 2.54313923 |
| 59 | Hyperlipoproteinemia (HP:0010980) | 2.51762787 |
| 60 | Gastrointestinal inflammation (HP:0004386) | 2.49736236 |
| 61 | Abnormality of the prostate (HP:0008775) | 2.49046049 |
| 62 | Abnormality of complement system (HP:0005339) | 2.46894809 |
| 63 | Abnormality of T cell physiology (HP:0011840) | 2.46796425 |
| 64 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.46203984 |
| 65 | Gingivitis (HP:0000230) | 2.45979080 |
| 66 | Keratoconjunctivitis (HP:0001096) | 2.45368866 |
| 67 | Colitis (HP:0002583) | 2.44624211 |
| 68 | Chronic diarrhea (HP:0002028) | 2.43667519 |
| 69 | Periodontitis (HP:0000704) | 2.43456078 |
| 70 | Chronic sinusitis (HP:0011109) | 2.43426496 |
| 71 | Spontaneous hematomas (HP:0007420) | 2.42296977 |
| 72 | Myocardial infarction (HP:0001658) | 2.40626779 |
| 73 | Cellulitis (HP:0100658) | 2.40273217 |
| 74 | Increased cerebral lipofuscin (HP:0011813) | 2.39970388 |
| 75 | Hypobetalipoproteinemia (HP:0003563) | 2.39014490 |
| 76 | Abnormality of B cell number (HP:0010975) | 2.38877671 |
| 77 | Recurrent sinusitis (HP:0011108) | 2.38604179 |
| 78 | Glomerulonephritis (HP:0000099) | 2.38513366 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 2.37020045 |
| 80 | Obstructive lung disease (HP:0006536) | 2.37020045 |
| 81 | Joint swelling (HP:0001386) | 2.36608829 |
| 82 | Reduced antithrombin III activity (HP:0001976) | 2.36521426 |
| 83 | Chest pain (HP:0100749) | 2.35930520 |
| 84 | Thrombophlebitis (HP:0004418) | 2.34273964 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.34238012 |
| 86 | Severe combined immunodeficiency (HP:0004430) | 2.33497208 |
| 87 | Pulmonary infiltrates (HP:0002113) | 2.32010801 |
| 88 | Hemoptysis (HP:0002105) | 2.29163491 |
| 89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.28375240 |
| 90 | Conjugated hyperbilirubinemia (HP:0002908) | 2.24994756 |
| 91 | Emphysema (HP:0002097) | 2.24310341 |
| 92 | Osteomyelitis (HP:0002754) | 2.23914435 |
| 93 | Dysostosis multiplex (HP:0000943) | 2.23745437 |
| 94 | Increased serum ferritin (HP:0003281) | 2.22614032 |
| 95 | Increased IgM level (HP:0003496) | 2.22227785 |
| 96 | Verrucae (HP:0200043) | 2.19679602 |
| 97 | Papilloma (HP:0012740) | 2.19679602 |
| 98 | IgG deficiency (HP:0004315) | 2.19400354 |
| 99 | Hypertensive crisis (HP:0100735) | 2.19019535 |
| 100 | Petechiae (HP:0000967) | 2.16248530 |
| 101 | Skin rash (HP:0000988) | 2.16054477 |
| 102 | Thrombocytosis (HP:0001894) | 2.14787577 |
| 103 | Abnormality of the pleura (HP:0002103) | 2.14136178 |
| 104 | Gastrointestinal infarctions (HP:0005244) | 2.11497727 |
| 105 | Microcytic anemia (HP:0001935) | 2.10867802 |
| 106 | Abnormal platelet function (HP:0011869) | 2.10671435 |
| 107 | Impaired platelet aggregation (HP:0003540) | 2.10671435 |
| 108 | Hemorrhage of the eye (HP:0011885) | 2.10575950 |
| 109 | Gangrene (HP:0100758) | 2.10090264 |
| 110 | Hypoplasia of the thymus (HP:0000778) | 2.09921137 |
| 111 | B lymphocytopenia (HP:0010976) | 2.09719493 |
| 112 | Anorexia (HP:0002039) | 2.08705196 |
| 113 | Lymphopenia (HP:0001888) | 2.05567936 |
| 114 | Skin ulcer (HP:0200042) | 2.05514252 |
| 115 | Hypochromic anemia (HP:0001931) | 2.05348209 |
| 116 | Cheilitis (HP:0100825) | 2.04904036 |
| 117 | Urticaria (HP:0001025) | 2.04600703 |
| 118 | Thyroid-stimulating hormone excess (HP:0002925) | 2.03859780 |
| 119 | Vascular calcification (HP:0004934) | 2.02458158 |
| 120 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02455842 |
| 121 | Purpura (HP:0000979) | 2.02222946 |
| 122 | Fat malabsorption (HP:0002630) | 2.01175715 |
| 123 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00984954 |
| 124 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00984954 |
| 125 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00984954 |
| 126 | Basal ganglia calcification (HP:0002135) | 2.00887971 |
| 127 | Abnormality of iron homeostasis (HP:0011031) | 2.00364377 |
| 128 | Combined immunodeficiency (HP:0005387) | 1.99488561 |
| 129 | Leukocytosis (HP:0001974) | 1.99343272 |
| 130 | Eosinophilia (HP:0001880) | 1.99253423 |
| 131 | Epidermoid cyst (HP:0200040) | 1.98142892 |
| 132 | Loss of speech (HP:0002371) | 1.96690596 |
| 133 | Sepsis (HP:0100806) | 1.94722286 |
| 134 | Fatigue (HP:0012378) | 1.91182284 |
| 135 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90874595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.97066767 |
| 2 | TXK | 3.41931959 |
| 3 | TYK2 | 3.23070073 |
| 4 | MAP3K14 | 3.20076760 |
| 5 | IKBKE | 3.01814464 |
| 6 | PRPF4B | 2.88393852 |
| 7 | IRAK3 | 2.87417207 |
| 8 | IRAK4 | 2.79630581 |
| 9 | JAK3 | 2.66459129 |
| 10 | FGFR4 | 2.48431023 |
| 11 | TBK1 | 2.40055459 |
| 12 | BLK | 2.38732465 |
| 13 | KIT | 2.35634793 |
| 14 | TAOK3 | 2.30220474 |
| 15 | JAK1 | 2.12367500 |
| 16 | IKBKB | 1.94370743 |
| 17 | BTK | 1.86161510 |
| 18 | TEC | 1.84918614 |
| 19 | ZAP70 | 1.83457372 |
| 20 | ERN1 | 1.81013669 |
| 21 | SMG1 | 1.70485255 |
| 22 | TRIB3 | 1.65374474 |
| 23 | NME2 | 1.64620288 |
| 24 | SYK | 1.53133155 |
| 25 | TLK1 | 1.47356544 |
| 26 | CDK12 | 1.47302372 |
| 27 | STK16 | 1.45600707 |
| 28 | ITK | 1.44413790 |
| 29 | MAP3K10 | 1.42008522 |
| 30 | ZAK | 1.39572576 |
| 31 | RIPK4 | 1.38378461 |
| 32 | PIM1 | 1.37499599 |
| 33 | MAP3K13 | 1.35324336 |
| 34 | TGFBR2 | 1.34846822 |
| 35 | CSF1R | 1.33749006 |
| 36 | LCK | 1.29264826 |
| 37 | HCK | 1.26338298 |
| 38 | TESK2 | 1.26024452 |
| 39 | FLT3 | 1.23626064 |
| 40 | GRK6 | 1.18021270 |
| 41 | LYN | 1.17674676 |
| 42 | TAOK1 | 1.15486875 |
| 43 | NLK | 1.15348357 |
| 44 | FGFR3 | 1.14914069 |
| 45 | CHUK | 1.14470493 |
| 46 | CSK | 1.13603132 |
| 47 | EEF2K | 1.12189027 |
| 48 | STK10 | 1.08916259 |
| 49 | IRAK1 | 1.08479814 |
| 50 | MAP2K3 | 1.06645999 |
| 51 | EIF2AK2 | 1.05202556 |
| 52 | MKNK2 | 1.03224052 |
| 53 | MAP3K1 | 1.02647091 |
| 54 | JAK2 | 1.01476989 |
| 55 | EPHA3 | 1.00796964 |
| 56 | STK4 | 1.00417875 |
| 57 | BCKDK | 0.97142005 |
| 58 | HIPK2 | 0.96886193 |
| 59 | TAOK2 | 0.96700182 |
| 60 | FES | 0.94125949 |
| 61 | CDC42BPA | 0.93477370 |
| 62 | MAP3K2 | 0.92689574 |
| 63 | RIPK1 | 0.92666478 |
| 64 | PIM2 | 0.91714912 |
| 65 | INSRR | 0.90025142 |
| 66 | YES1 | 0.89666295 |
| 67 | SIK1 | 0.84698729 |
| 68 | SCYL2 | 0.84192066 |
| 69 | MST4 | 0.79826073 |
| 70 | PRKD2 | 0.78800410 |
| 71 | MAPK11 | 0.78781194 |
| 72 | SIK3 | 0.78558234 |
| 73 | EPHB1 | 0.78028997 |
| 74 | PRKCQ | 0.77900943 |
| 75 | MST1R | 0.76124898 |
| 76 | CDK4 | 0.75581585 |
| 77 | FGR | 0.73487797 |
| 78 | KDR | 0.71930476 |
| 79 | TNK2 | 0.71177441 |
| 80 | GRK7 | 0.68399377 |
| 81 | MAP3K12 | 0.67450181 |
| 82 | PDPK1 | 0.64781357 |
| 83 | ICK | 0.62109193 |
| 84 | NEK9 | 0.61657567 |
| 85 | LRRK2 | 0.61600055 |
| 86 | PIK3CG | 0.61457845 |
| 87 | MATK | 0.61200987 |
| 88 | MAPK4 | 0.60793313 |
| 89 | RPS6KL1 | 0.59808425 |
| 90 | RPS6KC1 | 0.59808425 |
| 91 | ADRBK2 | 0.58239598 |
| 92 | BMPR2 | 0.56564654 |
| 93 | KSR2 | 0.56523411 |
| 94 | CAMK1D | 0.55588135 |
| 95 | CDK6 | 0.54740468 |
| 96 | TNIK | 0.54020071 |
| 97 | RPS6KA6 | 0.53674338 |
| 98 | MAPKAPK3 | 0.52883759 |
| 99 | MAP2K2 | 0.52849795 |
| 100 | CLK1 | 0.52786312 |
| 101 | CAMKK2 | 0.50955181 |
| 102 | MAPKAPK2 | 0.49855199 |
| 103 | RPS6KA5 | 0.49402067 |
| 104 | SIK2 | 0.48177656 |
| 105 | PTK6 | 0.47219763 |
| 106 | NUAK1 | 0.46146176 |
| 107 | RPS6KA4 | 0.43551220 |
| 108 | MELK | 0.43361546 |
| 109 | IRAK2 | 0.41895384 |
| 110 | MAP3K8 | 0.41748423 |
| 111 | PRKCD | 0.40058528 |
| 112 | ABL1 | 0.39884149 |
| 113 | MARK3 | 0.39857752 |
| 114 | CAMKK1 | 0.38663111 |
| 115 | MAP2K6 | 0.38602605 |
| 116 | STK24 | 0.38265513 |
| 117 | MARK2 | 0.37279413 |
| 118 | WNK4 | 0.37088282 |
| 119 | EIF2AK3 | 0.35783805 |
| 120 | PRKAA2 | 0.35442197 |
| 121 | MAPK7 | 0.35288862 |
| 122 | CDK9 | 0.34397860 |
| 123 | TRPM7 | 0.33779586 |
| 124 | PBK | 0.33083226 |
| 125 | MAP3K11 | 0.32430947 |
| 126 | EGFR | 0.31384507 |
| 127 | BMPR1B | 0.29931111 |
| 128 | VRK1 | 0.29767734 |
| 129 | PKN1 | 0.29707494 |
| 130 | GRK1 | 0.28787458 |
| 131 | IGF1R | 0.28417783 |
| 132 | PDK1 | 0.27692531 |
| 133 | SGK2 | 0.27031409 |
| 134 | MAP3K3 | 0.24009196 |
| 135 | ACVR1B | 0.23494270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.04565126 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.92384589 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.74154010 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.43870248 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.39384256 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.25286124 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.21604258 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.17947501 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.13629566 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.12059692 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.03348727 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.01112281 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.94296887 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.90313007 |
| 15 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.82842317 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82370557 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.75124806 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74659021 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.64994931 |
| 20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.62409935 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49641791 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.42307299 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42164999 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40942409 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39988791 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.38938434 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38200588 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.36947029 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33132392 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.32612369 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.31850139 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.30017759 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.29394387 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.28633330 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28022927 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24717702 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.24377207 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23638676 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.22745983 |
| 40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.21652994 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20468542 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16127747 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13636233 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13381969 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12528101 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 1.08621036 |
| 47 | Malaria_Homo sapiens_hsa05144 | 1.08081558 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07781334 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07756315 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.07338727 |
| 51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.04324998 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04114340 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02885679 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00421995 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.99168481 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.98783820 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.93678997 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91651205 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.90732936 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87724839 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85743859 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85383129 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83882632 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.83293732 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81685131 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81653172 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80621485 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80179636 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79730189 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77859008 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76259133 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75106292 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.74066510 |
| 74 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74041961 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73104335 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.70467996 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.68937342 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68922783 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68877418 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68841206 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67677368 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67188230 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67046744 |
| 84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66899363 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64993357 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.64953381 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.63955144 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62881789 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61272884 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61173381 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59902936 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59423674 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.58131486 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.57857116 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56878686 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53712740 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51398841 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49306931 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48721431 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47848067 |
| 101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47705121 |
| 102 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47628940 |
| 103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.46748866 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46702884 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46279966 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45601543 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45149155 |
| 108 | Lysosome_Homo sapiens_hsa04142 | 0.42205088 |
| 109 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41813367 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41101334 |
| 111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40199769 |
| 112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38239167 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37737909 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.37685504 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.37176374 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35411152 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.35184540 |
| 118 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35056754 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.34703087 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33942276 |
| 121 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32947109 |
| 122 | Bile secretion_Homo sapiens_hsa04976 | 0.32550252 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32187586 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31019131 |
| 125 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.30932106 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30809900 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30698446 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30513133 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.30169347 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30055172 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29118257 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27009939 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.24702293 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24684254 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24568113 |
| 136 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23238881 |
| 137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22869365 |
| 138 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21947393 |
| 139 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21371574 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.21290623 |
| 141 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21290130 |

